Bafna Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Cash & Equivalents	2.54	34.33	13.96	78.09	1.73	18.04	Upgrade
Cash & Short-Term Investments	2.54	34.33	13.96	78.09	1.73	18.04	Upgrade
Cash Growth	-80.65%	145.90%	-82.12%	4414.10%	-90.41%	-78.73%	Upgrade
Accounts Receivable	325.66	401.74	453.95	411.49	147.8	95.6	Upgrade
Other Receivables	-	-	-	-	-	109.7	Upgrade
Receivables	326.74	401.97	454.77	412.03	148.76	205.3	Upgrade
Inventory	309.99	280.86	296.42	222.2	202.81	154.43	Upgrade
Prepaid Expenses	-	5.21	4.61	3.73	-	2.34	Upgrade
Other Current Assets	161.39	139.43	167.95	157.07	155.5	116.57	Upgrade
Total Current Assets	800.66	861.79	937.71	873.12	508.8	496.68	Upgrade
Property, Plant & Equipment	796.68	660.93	507.07	402.3	388.46	367.98	Upgrade
Long-Term Investments	0.01	0.01	-	-	-	-	Upgrade
Other Intangible Assets	-	-	17.7	15	-	-	Upgrade
Other Long-Term Assets	9.49	8.07	14.34	5.42	4.19	-	Upgrade
Total Assets	1,607	1,531	1,477	1,296	901.45	864.66	Upgrade
Accounts Payable	260.24	309.45	354.22	284.61	124.05	106.92	Upgrade
Accrued Expenses	16.26	32.22	30.19	27.38	33.39	21.5	Upgrade
Short-Term Debt	-	85.7	100.11	119.09	45.92	100	Upgrade
Current Portion of Long-Term Debt	130.74	56	36.25	25.81	11.51	5	Upgrade
Current Income Taxes Payable	-	-	-	0.81	0.9	-	Upgrade
Current Unearned Revenue	1.66	1.66	0.99	0.99	0.66	-	Upgrade
Other Current Liabilities	69.28	33.49	19.07	6.07	3.71	9.67	Upgrade
Total Current Liabilities	478.16	518.52	540.83	464.76	220.13	243.09	Upgrade
Long-Term Debt	193.29	140.29	107.53	84.33	53.17	52.86	Upgrade
Long-Term Unearned Revenue	18.31	19.14	16.15	12.19	8.51	-	Upgrade
Other Long-Term Liabilities	4.78	4.78	3.92	-	-	1	Upgrade
Total Liabilities	694.55	682.73	668.43	561.29	281.81	296.95	Upgrade
Common Stock	236.56	236.56	236.56	236.56	236.56	236.56	Upgrade
Additional Paid-In Capital	-	753.77	753.77	753.77	753.77	753.77	Upgrade
Retained Earnings	-	-412.08	-451.75	-525.6	-640.51	-692.43	Upgrade
Comprehensive Income & Other	675.72	269.81	269.81	269.81	269.81	269.81	Upgrade
Total Common Equity	912.28	848.07	808.39	734.55	619.64	567.71	Upgrade
Shareholders' Equity	912.28	848.07	808.39	734.55	619.64	567.71	Upgrade
Total Liabilities & Equity	1,607	1,531	1,477	1,296	901.45	864.66	Upgrade
Total Debt	324.03	281.99	243.89	229.24	110.59	157.86	Upgrade
Net Cash (Debt)	-321.48	-247.66	-229.93	-151.15	-108.86	-139.82	Upgrade
Net Cash Per Share	-13.59	-10.47	-9.72	-6.39	-4.60	-5.90	Upgrade
Filing Date Shares Outstanding	23.67	23.66	23.66	23.66	23.66	23.66	Upgrade
Total Common Shares Outstanding	23.67	23.66	23.66	23.66	23.66	23.66	Upgrade
Working Capital	322.5	343.27	396.88	408.35	288.67	253.59	Upgrade
Book Value Per Share	38.54	35.85	34.17	31.05	26.19	24.00	Upgrade
Tangible Book Value	912.28	848.07	790.69	719.55	619.64	567.71	Upgrade
Tangible Book Value Per Share	38.54	35.85	33.42	30.42	26.19	24.00	Upgrade
Land	-	1.93	1.93	1.93	1.93	1.93	Upgrade
Buildings	-	275.1	251.51	250.78	245.71	225.35	Upgrade
Machinery	-	778.25	741.42	693.86	631.75	568.38	Upgrade
Construction In Progress	-	73.13	104.96	-	-	8.31	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.